TMCnet News
GST, PSTI, DMND, PRAN, LGND, TZF Are Seasonally Ripe To Go Down In the Next Five WeeksMay 16, 2013 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Gastar Exploration Ltd (AMEX:GST), Pluristem Therapeutics Inc (NASDAQ:PSTI), Diamond Foods Inc (NASDAQ:DMND), Prana Biotechnology Ltd (NASDAQ:PRAN), Ligand Pharmaceuticals Inc (NASDAQ:LGND), Bear Stearns Depositor Inc Trust Certificate Series 2001- 2 (NYSE:TZF) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php The following stocks are expected to go Down: Symbol Company Expected Return Odds By The Following Date GST Gastar Exploration Ltd -8.09% 100.00% (7 of 7) Thursday, May 23rd 2013 PSTI Pluristem Therapeutics Inc -7.04% 100.00% (10 of 10) Monday, May 27th 2013 DMND Diamond Foods Inc -3.07% 100.00% (7 of 7) Thursday, May 23rd 2013 PRAN Prana Biotechnology Ltd -8.74% 90.00% (9 of 10) Thursday, June 20th 2013 LGND Ligand Pharmaceuticals Inc -5.01% 84.62% (11 of 13) Wednesday, May 22nd 2013 TZF Bear Stearns Depositor Inc Trust Certificate Series 2001- 2 -2.66% 87.50% (7 of 8) Monday, May 27th 2013 Gastar Exploration Ltd (AMEX:GST) - Gastar Exploration Ltd., an independent energy company, engages in the exploration, development, and production of natural gas and oil in the United States. It focuses on the unconventional reserves, such as shale resource plays. As of December 31, 2011, the company had interests in the Marcellus Shale assets in West Virginia and Pennsylvania of approximately 43,400 gross acres; approximately 63,000 gross acres in Preston, Tucker, Pocahontas, Randolph, and Pendleton counties in West Virginia; and leases covering approximately 41,100 gross acres in the Bossier play in the Hilltop area of east Texas in Leon and Robertson counties. It also owned an average non-operated working interest on approximately 35,900 gross acres in the Powder River basin of Wyoming and Montana, as well as had proved undeveloped reserves of totaled 41.2 billion cubic feet of natural gas equivalent. Gastar Exploration Ltd. was founded in 1987 and is based in Houston, Texas.. Pluristem Therapeutics Inc (NASDAQ:PSTI) - Pluristem Therapeutics Inc., a bio-therapeutics company, engages in the research, development, and commercialization of standardized cell therapy products and related technologies for the treatment of life threatening diseases. The company s products are derived from human placenta that is a non-controversial, non-embryonic, and adult cell source. Its Placental adherent stromal cells are grown in the company's proprietary PluriX three-dimensional process that allows cells to grow in a natural environment. The company develops placenta expanded cells (PLX) and peripheral artery disease cells, an allogeneic therapeutic product that is in Phase-II clinical trials for the treatment of intermittent claudication, critical limb ischemia, and Buerger's disease. Its PLX product is developed for the treatment of muscle injury, bone marrow diseases, inflammatory bowel disease, and multiple sclerosis, as well as for pulmonary disorders, acute radiation syndrome, acute myocardial infarction, diabetic diastolic heart failure, neuropathic pain, inflammatory bowel disease, multiple sclerosis, and ischemic stroke for which the product is in various pre-clinical trials. Pluristem Therapeutics Inc. is also involved in the development and commercialization of a PLX cell-based product for the treatment of pulmonary arterial hypertension through its license agreement with the United Therapeutics Corporation. The company was formerly known as Pluristem Life Systems Inc. and changed its name to Pluristem Therapeutics Inc. in November 2007. Pluristem Therapeutics Inc. was founded in 2001 and is headquartered in Haifa, Israel.. Diamond Foods Inc (NASDAQ:DMND) - Diamond Foods, Inc., a packaged food company, engages in processing, marketing, and distributing snack products, culinary, in-shell, and ingredient/food service nuts. It provides snack products, including roasted, glazed and flavored nuts, trail mixes, granola, dried fruit, microwave popcorn products, and potato and tortilla chips under the Emerald, Pop Secret, and Kettle Brand names. The company also offers culinary, in-shell, and ingredient nuts under the Diamond of California brand through mass merchandisers and club stores. It markets its culinary nuts to individuals who prepare meals or baked goods at home; and ingredient nuts to food processors, restaurants, bakeries, and food service companies and their suppliers. The company distributes its products directly to national grocery, mass merchandiser, clubs, convenience stores, and drug store chains in the United States, Canada, Europe, and internationally. Diamond Foods, Inc. was founded in 1912 and is based in San Francisco, California.. Prana Biotechnology Ltd (NASDAQ:PRAN) - Prana Biotechnology Limited engages in the research and development of therapeutic drugs for the treatment of neurological disorders in Australia. The company primarily focuses on the Alzheimer s, Parkinson s, and Huntington s diseases, as well as various cancer, age-related macular degeneration and cataract, Motor Neuron, and Creutzfeldt-Jakob diseases. Its development stage product line comprises PBT2, a Phase IIb clinical trial product for the treatment of Alzheimer s disease; and PBT2, a Phase IIa clinical trial product for the treatment of Huntington s disease. The company was formerly known as Prana Corporation Ltd. and changed its name to Prana Biotechnology Limited in January 2000. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.. Ligand Pharmaceuticals Inc (NASDAQ:LGND) - Ligand Pharmaceuticals Incorporated, a biotechnology company, engages in the acquisition and development of royalty revenue generating assets in the United States. The company s assets include PROMACTA, an oral thrombopoietin receptor agonist therapy for the treatment of adult patients with chronic immune thrombocytopenic purpura; AVINZA, a pain therapeutic; Viviant/Conbriza for the treatment of postmenopausal osteoporosis; and Nexterone, an injectable formulation. Its late-stage development programs comprise PROMACTA, which has completed Phase III studies for thrombocytopenia in patients with hepatitis C; and is in Phase II clinical studies for the treatment of oncology-related thrombocytopenia in patients with solid tumors, sarcoma, and advanced Myelodysplastic Syndrome. In addition, the company s late-stage development programs also include Carfilzomib that is in Phase III studies for multiple myeloma; Aprela, which has completed Phase III studies for post-menopausal symptoms; Merck CAPTISOL program that is in Phase III studies; CAPTISOL-Enabled Clopidogrel, which is in Phase III studies for anti-coagulant; DARA program, a dual acting receptor antagonist that is in various stages of development for indications of severe kidney diseases. Further, its development programs comprise CAPTISOL-Enabled Melphalan IV, which is in pivotal Phase for the treatment of oncology diseases; HepDirect HCV Inhibitor that is preclinical Phase for the treatment of hepatitis C; IRAK4 Inhibitor, which is in Preclinical Phase for inflammation; Glucagon Receptor Antagonist that is in preclinical Phase for the treatment of diabetes; and CAPTISOL-Enabled Topiramate, which is in Phase II clinical trials for epilepsy. The company has strategic alliances or licensing agreements primarily with Chiva Pharmaceuticals, Inc., The Medicines Company, SAGE Therapeutics, Inc., Eli Lilly and Company, and Hospira, Inc. The company was founded in 1987 and is headquartered in La Jolla, California.. Bear Stearns Depositor Inc Trust Certificate Series 2001- 2 (NYSE:TZF) - Bear Stearns Depositor Inc. Trust Certificates Series 200121. SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements". RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO. INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports. Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks. Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups. Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks. GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time. About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades. SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin. All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind. Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC. Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 [email protected] SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Buyins.net Thomas Ronk [email protected] www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to [email protected]. |